Christopher L. Gentile

Papers

Total Citations

H-Index

About

Christopher L. Gentile is a surgical oncologist whose research focuses on refining transoral robotic surgery (TORS) for HPV-positive oropharyngeal squamous cell carcinoma (OPSCC). His major contribution centers on the clinical significance of initial incision margins (IIM) during TORS, demonstrating that positive deep IIM significantly impacts patient outcomes. In his landmark 2022 study, which has garnered 9 citations, Gentile conducted a retrospective chart review showing that achieving clear deep margins at the first incision is critical for reducing recurrence and improving survival in HPV+ OPSCC patients. This work provides actionable guidance for surgeons, emphasizing the need for precise intraoperative decision-making. Gentile’s research bridges surgical technique and oncologic outcomes, offering evidence that can directly influence operative protocols and postoperative management. His findings are particularly valuable for head and neck surgeons and oncologists seeking to optimize robotic surgery approaches. By highlighting the prognostic importance of initial margin status, Gentile has helped advance the standard of care in TORS, underscoring the interplay between surgical precision and patient prognosis in HPV-related oropharyngeal cancers.